Korean Chinese Japanese
  • Economy
  • Politics
  • Society
  • Securities
  • Real estate
  • Culture
  • Entertainment
  • Sports
  • Opinion
Korean Chinese Japanese
Economy Corporation Pharma & Bio
Society Politics IT·Science
Securities Real Estate Global
Opinion Entertainment Sports Culture
Video Auto in Golf in
PHARM EDAILY Market in TheBeLT
Corporation
Lifestyle

Aptabio Therapeutics Inc. Achieves Primary Endpoint in Global Phase 2 Trial of 'Isuzinacxib'

Aptabio Therapeutics Inc.(293780)has met the primary endpoint in the global Phase 2 clinical trial of “Isuzinacxib” (APX-115), which is being developed as a treatment for contrast-induced acute kidney…
  • 2026-10-15 09:36:01
  • KIM JI-WAN
Lifestyle

"A Taste and Feel of Seoul in Shibuya, Japan"... Shinsegae Co.,Ltd Hyperground Runs Through Next Month

Shinsegae Co.,Ltd announced on the 15th that it will host the “Hyperground: District Seoul – Shibuya Edition” pop-up event in Tokyo, Japan, to showcase Korean brands. Hyperground is a global expansion…
  • 2026-10-15 08:40:19
  • KYUNG GYEYOUNG
Electronics

SamsungElectronics Discusses 'Future Networks' with Global Telecommunications Companies in Silicon Valley

SamsungElectronics is expanding its collaboration with global telecommunications industry partners on next-generation network technologies based on artificial intelligence (AI). The company will discu…
  • 2026-10-15 08:32:02
  • SOYEON KIM
Lifestyle

Olix Pharmaceuticals, Inc. Plummets 14% After Clinical Trial Application Rejected; ROKIT HEALTHCARE Inc. Hits 52-Week Low [Bio Spotlight]

Olix Pharmaceuticals, Inc. plummeted more than 14% as the rejection of its application for a clinical trial in New Zealand for a potential treatment for age-related macular degeneration coincided with…
  • 2026-10-15 07:02:03
  • SONG YOUNG-DOO
Lifestyle

Celltrion Receives Approval for Phase 3 Clinical Trial of Zimpentra for Rheumatoid Arthritis in South Korea

Celltrion’s Zimpentra. (Photo courtesy of Celltrion) Celltrion(068270)Celltrion will conduct a global Phase 3 clinical trial in South Korea for “Zimpentra” (CT-P13 SC), a subcutaneous infliximab, …
  • 2026-10-14 18:40:03
  • SONG YOUNG-DOO
Business Community

Euisun Chung Bets 21 Trillion Won After Meeting Modi… Aims to Kill Two Birds with One Stone: A Huge Market and an Export Hub

HyundaiMotor Group Chairman Euisun Chung (left) is meeting with Prime Minister Narendra Modi at the Prime Minister’s official residence in New Delhi, India, on the 13th (local time). (Photo courtesy o…
  • 2026-10-14 18:29:21
  • Kim Hyung-wook
Electronics

Public and Private Sectors Collaborate on the Future of Housing… Samsung and LG Corp. Lead the K-GX Initiative with ‘AI Homes’ (Comprehensive)

SamsungElectronics and LGELECTRONICS have simultaneously unveiled future residential models that combine artificial intelligence (AI) home appliances with heat pumps and energy management technologies…
  • 2026-10-14 17:42:29
  • JAEMIN SONG
Electronics

“Samsung INICS Corporation Is Also in the Early Stages of Development”… The Threat of China’s 4F² Semiconductors: What’s the Reality?

As Chinese memory semiconductor company Changxin Memory Technology (CXMT) announced plans to adopt “4F²,” a next-generation DRAM technology for servers, SamsungElectronics revealed that it is also dev…
  • 2026-10-14 16:49:54
  • Choi Oh-hyun
Electronics

LGELECTRONICS Unveils Energy-Self-Sufficient Housing Concept with ‘Smart Cottage’… Minister Kim Seong-hwan Visits

On the 14th, LGELECTRONICS introduced a residential solution combining AI home appliances, heating, ventilation, and air conditioning (HVAC), and energy technologies to Kim Seong-hwan, Minister of Cli…
  • 2026-10-14 15:46:24
  • JAEMIN SONG
Electronics

SK Hanik’s Ahn Hyun: “AI Is Just Getting Started… A Golden Opportunity for South Korea”

Ahn Hyun, Executive Vice President of Development at SK hynix, emphasized, “Demand for artificial intelligence (AI) is just beginning,” adding, “AI technology is spreading at a pace humanity has never…
  • 2026-10-14 12:18:27
  • SOYEON KIM
prev 61 62 63 64 65 66 67 68 69 70 next

PHARM EDAILY

Shorts

EDAILY
  • 92, Tongil-ro, Jung-gu, Seoul, Korea
  • +82 2 3772 0114
  • webmaster@edaily.co.kr

※ This article has been translated using AI technology for the convenience of readers.

EDAILY provides this translation on an “as is” basis and makes no warranties, express or implied, regarding its accuracy, reliability, completeness, merchantability, or fitness for a particular purpose.
Due to the limitations of machine translation, the translated content may differ from the original Korean article. In the event of any discrepancy, the original Korean version shall prevail.
EDAILY shall not be liable for any loss or damage arising from the use of, or reliance on, the translated content.

© 2026 Copyrights by edaily. All Rights Reserved.
Korea China Japan
English